Ascentage Pharma Group International (AAPG) Operating Leases: 2022-2024

  • Ascentage Pharma Group International's Operating Leases rose 31.49% to $4.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.1 million, marking a year-over-year increase of 31.49%. This contributed to the annual value of $4.1 million for FY2024, which is 33.31% up from last year.
  • Per Ascentage Pharma Group International's latest filing, its Operating Leases stood at $4.1 million for Q4 2024, which was up 31.49% from $3.2 million recorded in Q4 2023.
  • Ascentage Pharma Group International's Operating Leases' 5-year high stood at $4.1 million during Q4 2024, with a 5-year trough of $2.4 million in Q4 2022.
  • Moreover, its 3-year median value for Operating Leases was $3.2 million (2023), whereas its average is $3.2 million.
  • Data for Ascentage Pharma Group International's Operating Leases shows a peak YoY spiked of 31.49% (in 2024) over the last 5 years.
  • Ascentage Pharma Group International's Operating Leases (Quarterly) stood at $2.4 million in 2022, then surged by 30.09% to $3.2 million in 2023, then surged by 31.49% to $4.1 million in 2024.
  • Its Operating Leases was $4.1 million in Q4 2024, compared to $3.2 million in Q4 2023 and $2.4 million in Q4 2022.